Use of the antiviral was linked to a significant decline in in-hospital death at both 14 and 28 days, regardless of variant of concern.
Remdesivir tied to 25% lower risk of in-hospital death in adults with COVID and no added oxygen
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Very few US adults getting new flu, COVID, RSV vaccines, even in nursing homes
- US respiratory virus activity remains low ahead of holiday season
- Antiviral COVID-19 drug molnupiravir tied to large drop in deaths in older patients
- Adults with migraines at higher risk of depression during pandemic, study shows